Market Place
Sourcing Support
Be Bio Announces $82M Financing And Clinical Stage Transition
22 Oct 2024 //
BUSINESSWIRE
Be Biopharma Announces Data For Engineered B Cell Medicine
30 Sep 2024 //
BUSINESSWIRE
Be Bio’s haemophilia B treatment gains FDA orphan drug status
05 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA: Orphan Status For BE-101 In Hemophilia B Treatment
04 Jun 2024 //
BUSINESSWIRE
Be Biopharma: FDA IND Clearance For BE-101 In Hemophilia B
28 May 2024 //
BUSINESSWIRE
Be Biopharma Expands SAB With Gene Therapy Leader Dr. Cannon
21 May 2024 //
BUSINESSWIRE
Be Bio Novel B Cell Hypophosphatasia Data
10 May 2024 //
BUSINESSWIRE
Be Biopharma to Present at ASGCT Annual Meeting
23 Apr 2024 //
BUSINESSWIRE
MaxCyte Signs Strategic Platform License with Be Biopharma
02 Apr 2024 //
GLOBENEWSWIRE
Be Biopharma to Present at the 20th Annual WORLDSymposium™ 2024
01 Feb 2024 //
BUSINESSWIRE
Be Biopharma to Present at Keystone Symposia on Emerging Cellular Therapies
25 Jan 2024 //
BUSINESSWIRE
Be Biopharma Expands Leadership Team
04 Jan 2024 //
BUSINESSWIRE
Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
28 Dec 2023 //
BUSINESSWIRE
Be Bio Announces Data Showing BE-101 Produces Active Levels of Factor IX
10 Dec 2023 //
BUSINESSWIRE
Be Biopharma Presents Data Showing B Cell Medicines Produce Antitumor Biologics
31 Oct 2023 //
BUSINESSWIRE
Be Biopharma to Present at 2023 Cell & Gene Meeting on the Mesa
11 Oct 2023 //
BUSINESSWIRE
Be Biopharma to Present at the Jefferies Healthcare Conference
25 May 2023 //
BUSINESSWIRE
Be Biopharma Appoints John Mayfield, Ph.D., as Chief Business Officer
08 Dec 2022 //
BUSINESSWIRE
Resilience inks manufacturing pact with ARCH-backed cell therapy startup
19 May 2022 //
ENDPTS
Be Bio raises $130m to develop engineered B cell medicines
15 Apr 2022 //
PHARMACEUTICAL-TECHNOLOGY
Be Bio Closes $130M Financing to Pioneer Engineered B Cells
14 Apr 2022 //
BUSINESSWIRE
Be Bio Appoints Mitchell Chan as CFO & Head of Corporate Strategy
21 Sep 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.